| |
| |
|
| Insider
Information: |
Hbm Bioventures Cayman Ltd |
| Relationship: |
10% Owner |
| City: |
Grand Cayman |
| State: |
E9 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
12 |
|
| Direct
Shares |
28,058,903 |
|
|
Indirect Shares
|
1,435,154 |
|
|
| Direct
Value |
$300,579,681 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
29,494,057 |
|
|
| Total
Value |
$300,579,681 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Icagen Inc |
ICGN |
10% Owner |
2005-02-08 |
1,200,000 |
2005-02-08 |
0 |
Premium* |
|
|
Harbor Brewing Company Inc |
HBWOD |
10% Owner |
2005-03-16 |
3,964,615 |
2005-03-16 |
1,435,154 |
Premium* |
|
|
Micrus Endovascular Corp |
MEND |
10% Owner |
2010-02-24 |
1,681,599 |
2005-06-21 |
0 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
10% Owner |
2013-03-25 |
2,233,993 |
|
0 |
Premium* |
|
|
PTC Therapeutics, Inc. |
PTCT |
10% Owner |
2013-12-17 |
2,441,504 |
2013-06-25 |
0 |
Premium* |
|
|
Iveric Bio Inc |
ISEE |
10% Owner |
2014-05-13 |
3,139,902 |
2013-09-30 |
0 |
Premium* |
|
|
Apollo Endosurgery, Inc |
APEN |
10% Owner |
2014-09-26 |
2,780,836 |
|
0 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2015-05-29 |
1,747,680 |
|
0 |
Premium* |
|
|
Nabriva Therapeutics AG |
NBRV |
10% Owner |
2017-09-14 |
2,334,128 |
|
0 |
Premium* |
|
|
Werewolf Therapeutics, Inc. |
HOWL |
10% Owner |
2021-05-04 |
625,995 |
2021-05-04 |
0 |
Premium* |
|
|
Io Biotech, Inc. |
IOBT |
10% Owner |
2021-11-09 |
2,690,545 |
2021-11-09 |
0 |
Premium* |
|
|
Mineralys Therapeutics, Inc. |
MLYS |
10% Owner |
2023-02-14 |
3,218,106 |
2023-02-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
104 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCRX |
Pacira Pharmaceuticals, I... |
10% Owner |
– – • |
2013-03-11 |
4 |
AS |
$27.86 |
$13,930,000 |
D/D |
(500,000) |
2,933,993 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
10% Owner |
– – • |
2013-03-18 |
4 |
AS |
$28.19 |
$11,277,480 |
D/D |
(400,000) |
2,533,993 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
10% Owner |
– – • |
2013-03-19 |
4 |
AS |
$27.86 |
$253,501 |
D/D |
(9,100) |
2,524,893 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
10% Owner |
– – • |
2013-03-21 |
4 |
AS |
$27.50 |
$314,353 |
D/D |
(11,431) |
2,513,462 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
10% Owner |
– – • |
2013-03-22 |
4 |
AS |
$27.52 |
$3,135,595 |
D/D |
(113,928) |
2,399,534 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
10% Owner |
– – • |
2013-03-25 |
4 |
AS |
$28.28 |
$4,680,738 |
D/D |
(165,541) |
2,233,993 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
10% Owner |
– – • |
2013-06-25 |
4 |
B |
$15.00 |
$10,000,140 |
D/D |
666,676 |
2,508,171 |
2.45 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
10% Owner |
– – • |
2013-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,841,495 |
1,841,495 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
10% Owner |
– – • |
2013-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,411,901 |
3,411,902 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
10% Owner |
– – • |
2013-09-30 |
4 |
B |
$22.00 |
$5,016,000 |
D/D |
228,000 |
3,639,902 |
2.45 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
10% Owner |
– – • |
2013-12-17 |
4 |
S |
$19.08 |
$1,272,120 |
D/D |
(66,667) |
2,441,504 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
10% Owner |
– – • |
2014-05-13 |
4 |
S |
$29.75 |
$14,875,000 |
D/D |
(500,000) |
3,139,902 |
0 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
10% Owner |
– – • |
2014-09-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,780,836 |
|
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2014-10-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,768,260 |
|
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2015-05-28 |
4 |
S |
$31.52 |
$334,985 |
D/D |
(10,580) |
1,757,680 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2015-05-29 |
4 |
S |
$29.52 |
$297,908 |
D/D |
(10,000) |
1,747,680 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2016-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
275,988 |
|
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2017-04-06 |
4 |
S |
$11.20 |
$350,160 |
D/D |
(31,217) |
244,771 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2017-04-06 |
4/A |
S |
$11.20 |
$350,160 |
D/D |
(31,217) |
2,728,663 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2017-04-07 |
4/A |
S |
$10.96 |
$235,931 |
D/D |
(21,501) |
2,707,162 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2017-04-07 |
4 |
S |
$10.96 |
$235,931 |
D/D |
(21,501) |
223,270 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2017-04-10 |
4 |
S |
$10.73 |
$406,451 |
D/D |
(37,876) |
185,394 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2017-04-10 |
4/A |
S |
$10.73 |
$406,451 |
D/D |
(37,876) |
2,669,286 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2017-04-11 |
4 |
S |
$11.40 |
$98,034 |
D/D |
(8,597) |
2,660,689 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
10% Owner |
– – • |
2017-04-12 |
4 |
S |
$11.22 |
$148,653 |
D/D |
(13,250) |
2,647,439 |
0 |
- |
|
104 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
